Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,040 papers from all fields of science
Search
Sign In
Create Free Account
Leptospira interrogans serovar Canicola Ab:PrThr:Pt:Ser:Ord
Known as:
Leptospira interrogans sv Canicola Ac [Presence] in Serum
, Leptospira interrogans serovar Canicola ??:PrThr:??????:???:???
, Leptospira interrogans serovar Canicola Ac:PrThr:Temps ponctuel:Sérum:Ordinal
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Antibodies
Leptospira
Leptospira interrogans
Microbiology procedure
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Highlights from the advanced wound healing stream at the LINK Congress.
S. Kahn
British Journal of Nursing
2017
Corpus ID: 207251454
Sarah Kahn, Editor of the British Journal of Nursing, discusses some highlights of the recent Hartmann LINK for Wound Healing…
Expand
Review
2013
Review
2013
High prevalence of antibodies against Leptospira spp. in male Austrian adults: a cross-sectional survey, April to June 2009.
W. Poeppl
,
M. Orola
,
+6 authors
H. Burgmann
Euro surveillance : bulletin Europeen sur les…
2013
Corpus ID: 12866139
To assess the distribution of specific antibodies against Leptospira spp. in Austrian adults, we conducted an explorative…
Expand
Review
2013
Review
2013
Canine anti-leptospira bacterins commercialized in Brazil : a challenge made with indigenous strains of serovars Canicola and Copenhageni
Wilsilene Aparecida Silva Coelho
,
S. Vasconcellos
,
+5 authors
F. Soto
2013
Corpus ID: 44189118
It was performed a comparative potency evaluation of canine anti-leptospira vaccines commercialized in Brazil, using for the…
Expand
Review
2008
Review
2008
Seroepidemiology of canine leptospirosis in Ahvaz, Iran
R. Avizeh
,
M. Ghorbanpoor
,
S. Hatami
,
Gholamreza Abdollahpor
2008
Corpus ID: 54510339
Abstract: The presence of dogs has been identified as a risk factor for human Leptospirosis. The aim of this study was the survey…
Expand
2007
2007
Natural Infection of Pachysentis canicola (Acanthocephala: Oli- gacanthorhynchida) In Fox from Persian Gulf Coastal Area in Iran
I. Mobedi
,
G. Mowlavi
,
A. Rahno
,
K. T. Mobedi
,
A. Mojaradi
2007
Corpus ID: 85931352
canicola (Meyer, 1931) is an acanthocephalan belonging to the class Oligacanthorhynchida. These species parasitize canids and…
Expand
2007
2007
Confirmación microbiológica de 2 brotes emergentes de leptospirosis humana en Cuba
I. R. González
,
C. Molina
,
+5 authors
A. Hernández
2007
Corpus ID: 132336305
Se estudiaron muestras clinicas de 293 pacientes con sospechas de leptospirosis, para la confirmacion microbiologica de estos…
Expand
1952
1952
Der Goldhamster als Versuchstier für Leptospira canicola
F. Bürki
Zeitschrift für Medizinische Mikrobiologie und…
1952
Corpus ID: 30584988
ZusammenfassungDer Goldhamster hat sich zu Arbeiten mitLeptospira canicola dem Meerschweinchen als überlegen erwiesen. Auf Grund…
Expand
1952
1952
Eigene Beobachtungen bei einer Leptospiroseepidemie in Schleswig-Holstein
F. Fühner
Zeitschrift für Medizinische Mikrobiologie und…
1952
Corpus ID: 27672229
ZusammenfassungEs wurde durch Nachuntersuchungen gezeigt, daß die vonGlattkowski beschriebene „Canicola-Epidemie“ zwar als…
Expand
1952
1952
Zur Erzeugung der sog. neuralen Dystrophie nach A.D.Speransky
H. Reitter
,
R. Ritter
1952
Corpus ID: 89030673
ZusammenfassungVersuche vonSperansky-Schülern, P. N.Kartaschow u. L. M.Matwejewa, zur Erzeugung neurodystrophischer…
Expand
1949
1949
Über die Antigendifferenzierung bei Leptospiren mit Hilfe des Pfeifferschen Versuches
Ines Blindenhöfer
Zeitschrift für Medizinische Mikrobiologie und…
1949
Corpus ID: 12265449
Zusammenfassung1.Auf Grund von Versuchen, die nach der Methode desPfeifferschen Versuches an Ratten durchgeführt wurden, läßt…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE